Hong Xie

Prof. Hong Xie


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2021 in Respiratory Research
Verified
Journal Article
Open access
PDF file
YLYaling Liu
Yaling Liu
XWXiaodong Wang
Xiaodong Wang
PLPeiying Li
Peiying Li
YZYanhua Zhao
Yanhua Zhao
LYLiqun Yang
Liqun Yang
HXHong Xie
Hong Xie
Background: ALI/ARDS is a severe lung injury leading to refractory respiratory failure, accounting for high morbidity and mortality. However, therapeutic approaches are rather limited. Targeting long non-coding RNA MALAT1 and microRNA miR-181a-5p might be potential option for ALI/ARDS intervention. Objective: We aimed to investigate the role of MALAT and miR-181a-5p in the pathogenesis of ALI/ARDS, and test the therapeutic effects of targeting MALAT and miR-181a-5p for ALI/ARDS intervention in vitro. Methods: MALAT1 and miR-181a-5p levels were measured in plasma from ALI/ARDS patients. In vitro human pulmonary microvascular endothelial cell (HPMEC) injury was induced by LPS treatment, and molecular targets of MALAT1 and miR-181a-5p were explored by molecular biology approaches, mainly focusing on cell apoptosis and vascular inflammation. Interaction between MALAT1 and miR-181a-5p was also detected. Finally, the effects of targeting MALAT1 and miR-181a-5p for ALI/ARDS intervention were validated in a rat ALI/ARDS model. Results: MALAT1 upregulation and miR-181a-5p downregulation were observed in ALI/ARDS patients. Transfection of mimic miR-181a-5p into HPMECs revealed decreased Fas and apoptosis, along with reduced inflammatory factors. Fas was proved to be a direct target of miR-181a-5p. Similar effects were also present upon MALAT1 knockdown. As for the interaction between MALAT1 and miR-181a-5p, MALAT1 knockdown increased miR-181a-5p expression. Knocking down of MALAT1 and miR-181a-5p could both improve the outcome in ALI/ARDS rats. Conclusion: MALAT1 antagonism or miR-181a-5p could both be potential therapeutic strategies for ALI/ARDS. Mechanistically, miR-181a-5p directly inhibits Fas and apoptosis, along with reduced inflammation. MALAT1 negatively regulates miR-181a-5p.

27 November 2019 in Acta Pharmacologica Sinica
Verified
Journal Article
Closed access
PDF file
JZJiang Zhu
Jiang Zhu
YWYi-Fei Wang
Yi-Fei Wang
XCXiao-Ming Chai
Xiao-Ming Chai
KQKe Qian
Ke Qian
LZLing-Wei Zhang
Ling-Wei Zhang
HXHong Xie
Hong Xie

11 October 2019 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
BYBo Yang
Bo Yang
JXJunjie Xu
Junjie Xu
LCLiuhui Chang
Liuhui Chang
ZMZhigang Miao
Zhigang Miao
DHDara Heang
Dara Heang
HXHong Xie
Hong Xie

1 August 2021 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
DHDan Huang
Dan Huang
SZShujing Zhou
Shujing Zhou
ZYZhangjie Yu
Zhangjie Yu
JCJie Chen
Jie Chen
HXHong Xie
Hong Xie

1 November 2020 in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
Verified
Journal Article
Closed access
XLXiaopan Luo
Xiaopan Luo
LCLong Chen
Long Chen
YZYunlong Zhang
Yunlong Zhang
JLJintao Liu
Jintao Liu
HXHong Xie
Hong Xie

10 February 2022 in European Journal of Pharmacology
Verified
Journal Article
Closed access
LZLi Zhou
Li Zhou
QXQian Xie
Qian Xie
QZQuanyun Zhang
Quanyun Zhang
MHMengxi Hu
Mengxi Hu
TMTengfei Ma
Tengfei Ma
HXHong Xie
Hong Xie